Profil bibliographique

M. Pérol

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

625Publications signalées

20233Citations signalées

2Affiliations récentes

Institutions déclarées

Centre Léon Bérard Centre de Recherche en Cancérologie de Lyon

Domaines associés

Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Publications récentes

2026 articleOpenAlex

Fusion isoform multiplicity and impact on treatment outcomes in ALK-rearranged non-small cell lung cancer with next-generation tyrosine kinase inhibitors

Damien Humbert, Adrien Buisson, Mathurine Basset, Anne-Claire Toffart et autres

0 citationsLung Cancer

2026 articleOpenAlex

Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial

Xiuning Le, Antonio Passaro, Yuanyuan Zhao, Yan Huang et autres

0 citationsThe Lancet Oncology

Accès ouvert 2026 articleOpenAlex

Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France

Nicolas Girard, Matthieu Carton, P. Macouillard, D. Debieuvre et autres

0 citationsLung Cancer

Accès ouvert 2026 articleOpenAlex

Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison

Misako Nagasaka, Geoffrey Liu, M. Pérol, W Chen et autres

0 citationsLung Cancer

Accès ouvert 2026 preprintOpenAlex

Multimodal profiling for prediction of primary resistance to anti–PD-(L)1 therapy in advanced non-small-cell lung cancer: the prospective PIONeeR biomarkers study

Fabrice Barlési, Florence Monville, Frédéric Vely, Laurent Greillier et autres

0 citationsmedRxiv

Accès ouvert 2025 articleOpenAlex

Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in France

M. Pérol, Clarisse Audigier-Valette, H. Léna, Marie-Ange Massiani et autres

0 citationsRespiratory Medicine and Research

2025 conference-abstractOpenAlex

PCR212 Satisfact-Home: Perception of Care Quality and Quality of Life in Patients With Solid Tumors Receiving Immune Checkpoint Inhibitors (ICIs) Therapy From Hospital To Home: A French Multicenter Prospective Observational Study

Anne Claire Toffart, Cécile Di Santolo, Laure Guéroult-Accolas, Nicolas Meyer et autres

0 citationsValue in Health

2025 conference-abstractOpenAlex

RWD164 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Previously Treated With First-Line (1L) Platinum-Based Chemotherapy (PBC)

Élisa Gobbini, P. Macouillard, Marian Eberl, Shannon Hunter et autres

0 citationsValue in Health

2025 conference-abstractOpenAlex

CO121 External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)

C. Chouaid, Nicolas Girard, Louise Baschet, Xavier Quantin et autres

0 citationsValue in Health

Accès ouvert 2025 articleOpenAlex

The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy

Caroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, Emmanuel Grolleau et autres

0 citationsEuropean Journal of Cancer

Accès ouvert 2025 articleOpenAlex

Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases

Pasi A. Jänne, David Planchard, Kōichi Goto, Egbert F. Smit et autres

17 citationsJAMA Network Open

Accès ouvert 2025 articleOpenAlex

Prognostic factors and outcomes of patients with advanced non-small-cell lung cancer treated with osimertinib: a retrospective database study

M. Pérol, C. Chouaïd, P. Macouillard, L. Bosquet et autres

0 citationsESMO Real World Data and Digital Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.